Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rhett Jiles"'
Autor:
Amado J. Zurita, Peter Kuhn, James Hicks, Ryan Dittamore, Ana M. Aparicio, Paul Corn, Nicholas E. Navin, Christopher Logothetis, Anand Kolatkar, Emi Sei, Carmen Ruiz Velasco, Rhett Jiles, Ramsay Sutton, Jerry Lee, Naveen Ramesh, Angel Rodriguez, Ryon P. Graf, Paymaneh D. Malihi
Figures and Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199918d1c454bdbd6357f15a377f293d
https://doi.org/10.1158/1078-0432.22477100.v1
https://doi.org/10.1158/1078-0432.22477100.v1
Autor:
Amado J. Zurita, Peter Kuhn, James Hicks, Ryan Dittamore, Ana M. Aparicio, Paul Corn, Nicholas E. Navin, Christopher Logothetis, Anand Kolatkar, Emi Sei, Carmen Ruiz Velasco, Rhett Jiles, Ramsay Sutton, Jerry Lee, Naveen Ramesh, Angel Rodriguez, Ryon P. Graf, Paymaneh D. Malihi
Purpose:Aggressive variant prostate cancer (AVPC) represents a clinical subset distinguished by therapy resistance and poor prognosis, linked to combined losses of the tumor suppressor genes (TSG) PTEN, RB1, and TP53. Circulating tumor cells (CTC) pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2056e20673c4708b30a5976f888cf53e
https://doi.org/10.1158/1078-0432.c.6529574
https://doi.org/10.1158/1078-0432.c.6529574
Autor:
Emi Sei, Ana Aparicio, Ryon P. Graf, Christopher J. Logothetis, Carmen Ruiz Velasco, James W. Hicks, Naveen Ramesh, Rhett Jiles, Ramsay Sutton, Anand Kolatkar, Peter Kuhn, Paymaneh D. Malihi, Angel Rodriguez, Ryan Dittamore, Paul G. Corn, Nicholas Navin, Jerry Lee, Amado J. Zurita
Publikováno v:
Clin Cancer Res
Purpose: Aggressive variant prostate cancer (AVPC) represents a clinical subset distinguished by therapy resistance and poor prognosis, linked to combined losses of the tumor suppressor genes (TSG) PTEN, RB1, and TP53. Circulating tumor cells (CTC) p
Autor:
Melanie Hulling, Jerry Lee, Nadia Ebrahim, Joseph D. Schonhoft, Mark Landers, Yipeng Wang, Ethan Barnett, Ryan Dittamore, Rhett Jiles, Ramsay Sutton, Charles M. Rudin, Emily Carbone, Robin Richardson, Howard I. Scher, John T. Poirier, Angel Rodriguez, Luisa Fernandez
Publikováno v:
Cancer Research. 79:1348-1348
Background: Clinical benefit in response to chemotherapeutic agents that induce replication stress such as PARP inhibitors and cisplatin has been associated with mutations in DNA damage repair (DDR) genes. However, prediction of benefit is not solely
Autor:
Rhett Jiles, Ramsay Sutton, Ryan Dittamore, Jerry Lee, Yipeng Wang, Angel Rodriguez, Gordon Vansant, Mark Landers
Publikováno v:
Cancer Research. 78:3616-3616
Background: Recent studies show tumor mutation burden (TMB) is a biomarker for patient responses to immune checkpoint inhibitors whereas chromosomal instability (CIN) is a marker for PARP inhibitors drug response. Assessment of TMB and CIN in bulk tu
Autor:
Rhett Jiles, Angel Rodriguez, Mark Landers, Ryan Dittamore, Jerry Lee, Yipeng Wang, Ramsay Sutton
Publikováno v:
Molecular Cancer Therapeutics. 17:A061-A061
Background: Genomic instability (GI) is a hallmark of cancer often associated with poor patient outcome. TMB, MSI, and CIN represent the majority of GI in metastatic patients. Recent studies show that TMB and MSI are emerging immune checkpoint inhibi